An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

Status:
Completed

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

The primary objective of the trial is to assess the tolerability and safety of long-term SPM 927 administration in subjects with diabetic neuropathy.

Phase 2

UCB Pharma

Lacosamide